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The present benefit and risk assessment of breastmilk and contaminants in breastmilk was initiated 
by the Norwegian Scientific Committee for Food Safety (VKM). The overall objective is to provide a 
balanced assessment of the benefits of breastmilk against the possible risks from exposure to 
contaminants in breastmilk with focus on Norwegian conditions. The aim is to contribute to a 
foundation for decision-makers when providing recommendations on the length of exclusive and 
partial breastfeeding. 
 
The composition of breastmilk is tailored for the needs of the newborn. Provided that the nutritional 
needs of the mother are met during pregnancy and breastfeeding, breastmilk covers all the 
nutritional requirements of the infant the first months of life, with the exception of vitamin D. 
Breastmilk also contains a number of specialised components, including growth factors, factors 
with anti-microbial and anti-inflammatory properties and selected immunological components which 











boost the maturation of the infant’s immune system. Infant formula fulfils the infant’s established 
nutritional needs, but does not provide the specific protective factors which are present only in 
breastmilk. 
 
However, studies over the last four decades have shown that polluting chemicals have 
accumulated in the environment, biomagnified in the food chain, are in our bodies, and 
consequently in breastmilk. The levels of lipid-soluble persistent contaminants in the foetus, the 
newborn child and in breastmilk largely reflect the amount of these in the mother’s body.  
 
Thus, breastmilk contains nutrients and protective immunological factors which have a positive 
effect on infant health, but may also contain contaminants. Particularly lipid-soluble and persistent 
contaminants accumulate in the infant during breastfeeding. This has contributed to a debate 
among experts agreeing that breastfeeding is beneficial, but discussing the advisable length of 
breastfeeding.  
 
Breastfeeding in Norway 
 
Breastfeeding prevalence is higher in Norway than in most European countries. 80% of the infants 
are breastfed at 6 months of age and 46% at 12 months. Mean breastfeeding duration is about 10 
months.  
 
Norwegian health authorities recommend that infants are exclusively breastfed for 6 months with a 
total duration of at least 12 months. However, only a minority of Norwegian mothers breastfeed 
exclusively for the recommended 6 months. The prevalence of exclusive breastfeeding declines 
rapidly from 3 months onwards with only 9% being exclusively breastfed at 6 months.  
 
Mean breastmilk consumption in exclusively breastfed infants increases from approximately 700 
ml/day at age 1 month to 850 ml/day at age 6 months. The amount of breastmilk provided to the 
child is not very different between the partially and exclusively breastfed infants during the first 4 
months. From 7 months, breastmilk consumption in partially breastfed infants may be about 500 
ml/day.  
 
There are a few conditions where breastfeeding is contraindicated. Among these are some 
metabolic disorders, infections and use of certain pharmaceuticals. 
 
Nutrients and Immunological Components in Breastmil k 
 
The positive health effects of breastmilk relates to nutritious as well as immunological properties.  
 
An infant who is exclusively breastfed for the first 6 months of life has, provided adequate nutrition 
of the mother, all the nutritional needs covered with the exception of vitamin D. Therefore, 
worldwide, the recommended daily intake of nutrients for infants is derived from the nutrient 
concentrations in breastmilk multiplied with the average intake of breastmilk.  
 
The composition of nutrients in breastmilk varies by stage of lactation, the time of day and during a 
given feeding. The concentration of some nutrients also varies according to the mother’s diet. The 
energy content of breastmilk varies, but has been estimated to be about 700 kcal/L. The content of 
proteins and carbohydrates is relatively stable, while the fat content has large variations. The fatty 
acid composition and concentrations of most vitamins reflect the maternal intake, while the 
concentrations of most minerals are not affected by the maternal diet, except for selenium and 
iodine.  
 
Breastmilk has protective properties. It contains a number of specialised components, including 
factors with anti-microbial and anti-inflammatory properties as well as constituents boosting the 
maturation of the infant’s immune system. This benefits health in childhood and most likely also 
later in life. The milk antibodies are targeted against potential pathogens and other antigens to 











influenced by contact with the immune-modulating factors in breastmilk as well as dietary and 
microbial constituents in the infant’s gut. Different components in breastmilk facilitate the 
establishment of a beneficial intestinal microbiota, which is important for induction of a balanced 
mucosal immune system. Through all these mechanisms, breastfeeding represents an ingenious 
immunologic integration of mother and child.  
 
Nutrients in Infant Formula 
 
If breastfeeding is not possible or if there is a need for more milk in addition to breastmilk, infant 
formula is recommended until the child is 12 months of age.  
 
Infant formula fulfills the infant´s established nutritional needs, but does not provide maternal 
antibodies and innate defence factors or immunity-promoting components. The majority of the 
infant formulas on the Norwegian market are cow’s milk-based. 
 
Data from a national dietary survey among infants (Spedkost, 2006) showed that at 6 months of 
age, 43% of the infants in Norway had been introduced to infant formula, and 36% used it 
regularly. At 1 year of age, 43% of the infants received infant formula regularly.  
 
Infant formulas in Norway are subject to EU regulations that cover the composition, labelling, 
marketing and distribution of the product. The regulations give minimum and maximum limits for 
nutrients for infant formulas and include some of the provisions of the WHO Code1. 
  
Contaminants and Microbiological Organisms in Breas tmilk and Infant Formula   
 
Breastmilk, as a reflection of the mother’s body, contains low concentrations of a mixture of 
different contaminants. Only the most prevalent contaminants in breastmilk have been determined 
chemically and even fewer have been studied in humans with regard to impact on early life health.  
 
The main focus of the present benefit and risk assessment of breastmilk are contaminants which 
are included in the Stockholm convention on Persistent Organic Pollutants (POPs)2. They can be 
divided into the three main groups; pesticides (DDT and HCB), other halogenated organic 
pollutants (dioxins and dioxin-like PCBs, non-dioxin-like PCBs, brominated flame retardants 
(PBDE), perfluorinated compounds (PFOS/PFOA)) and heavy metals (lead, mercury and 
cadmium). 
 
In the identification and characterisation of negative health effects, combined exposures to multiple 
contaminants3 from breastmilk have to some extent been taken into consideration, as several of 
the cohorts have been investigating the impact on health outcomes of PCBs and dioxins in 
combination with DDT or HCB and some in combination with mercury. Additionally, it should be 
noted that the contaminants studied may be considered as markers for the combined exposure of 
multiple contaminants, since their occurrences are often correlated. 
 
Metal concentrations in both breastmilk and infant formula (e.g. mercury and lead) are generally 
low and not at levels associated with concern.  
 
Due to national and international restrictions and bans on use, the levels of dioxins, PCBs, and 
pesticides (like DDTs and HCB) have declined substantially (more than 60%) in the environment 
and in humans the last three decades. Compared to DDTs, HCB, dioxins and PCBs, the 
concentration of PBDEs in breastmilk in Norway increased until approximately year 2000, after 
which a decline has been observed. The fluorinated surfactants PFOS and PFOA have shown a 
similar time trend as the PBDEs. 
                                                           
1International Code of marketing of Breast-Milk substitutes. 
2The Stockholm Convention (SC) on Persistent Organic Pollutants (POPs) is a global treaty administered by the United Nations 
Environment Programme (UNEP) to protect human health and the environment from chemicals, and first entered into force in 
2004 (Stockholm Convention on POPs 2004 http://www.chm.pops.int). The criteria for being included in SC are persistence, 
bioaccumulation, potential for long-range transport, and adverse effects. 











There are limited Norwegian data on levels of persistent organic pollutants in infant formula, but 
the levels reported are generally much lower than in breastmilk. 
 
Some contaminants which do not accumulate in the food chain may also be relevant in both 
breastmilk and infant formula. Substances from food packaging materials, e.g. phthalates, may be 
present in both breastmilk and infant formula, as well as process-generated substances such as 
acrylamide, PAHs, furan and 3-MDCP. The hormone active substance bisphenol A (BPA) used in 
plastic has recently been banned in infant feeding bottles in EU and Norway. Occurrence data in 
breastmilk and infant formula for these substances in Norway are scarce.  
 
The main difference between the contaminants in breastmilk and those provided by infant formula 
or bottle-feeding is that breastmilk generally contains higher levels of persistent organic pollutants, 
while most of the unwanted substances imposed by infant formula and bottle-feeding have a 
shorter half-life.  
 
Infant formula may contain microbial contamination of concern, which may lead to diarrhea and in 
severe cases bacteraemia and meningitis. Cronobacter spp. (formerly Enterobacter sakazakii) is a 
rare cause of invasive infection with high death rates in newborn infants. Possible outbreak from 
microbiological hazards in infant formula itself or due to contaminated water is an issue in 
developing countries, but no such outbreaks have been registered in Norway.  
 
Methodological Approach to this Benefits and Risk A ssessment 
 
The benefit assessment is based on positive health effects reported in systematic reviews and 
meta-analyses published within the last 10 years. This implies that VKM has not conducted its own 
specific literature search to reveal the epidemiological studies that have examined positive health 
effects of breastmilk, but summarises and discusses the health outcomes described in the included 
systematic reviews and meta-analyses4. 
 
In addition, some other reviews or single studies of high quality have been included if recent 
publications of relevance to the benefit assessment have appeared, or the above described 
reviews and meta-analyses have not commented on diseases/conditions of interest. In the VKM 
conclusions, most emphasis has been put on two recent systematic reviews; one from Nordic 
Nutrition Recommendations (2013) and one from WHO (2013).  
 
As a basis for the risk assessment to identify and characterise possible negative effects of 
contaminants in breastmilk, a full scale systematic literature search for single studies investigating 
such effects associated with exposure to contaminants in breastmilk was conducted. 
 
It was set as an absolute inclusion criterion that the studies should provide good breastfeeding 
data and be able to differentiate effects of postnatal exposure from prenatal exposure. 
 
The systematic literature search resulted in 46 studies which were rated for quality (A-B-C) 
according to a predefined set of criteria. Of these, no studies were categorised as A, while 24 
studies qualified for category B. The category C-studies were not considered further. The negative 
health effects of contaminants in breastmilk in this report are thus based on 24 papers from 10 
cohorts conducted in seven different countries (USA, Canada, Faroe Isles, Spain, Germany, the 
Netherlands and Slovakia). No such data on impact on infant and child health of exposure to 
contaminants via breastmilk was available from Norway. Only the contaminants PCBs, dioxins, 
DDT/DDE, HCB and mercury were investigated in the included studies. 
 
                                                           
4The included systematic reviews and meta-analyses are: Breast-feeding: A Commentary by the ESPGHAN Committee on 
Nutrition (including a previous WHO-report from 2007, and two other systematic reviews from 2005 and 2007). The influence of 
maternal, fetal and child nutrition on the development of chronic disease in later life from the Scientific Advisory Committee on 
Nutrition in UK from 2011. Breastfeeding, introduction of other foods and effects on health: A systematic literature review for the 














There are several methods in use for grading evidence in systematic literature reviews. The 
grading of evidence used in this benefit and risk assessment is similar to the grading system used 
by the World Cancer Research Fund (WCRF) in the report Food, Nutrition, Physical Activity and 
the prevention of Cancer: a global perspective from 2007. 
 




• Limited – suggestive 
• Limited – no conclusion 
 
When grading the evidence of the literature on positive health effects associated with breastmilk, 
VKM has graded the sum of the work by others, some of whom have not graded their results and 
some using grading, but various grading systems. An element of “best judgement” is thus 
unavoidable from our side, as there to our knowledge are no international guidelines for grading on 
the basis of reviews and meta-analyses. 
 
Breastfeeding Data in Meta-analyses and Reviews for  Positive Health Effects 
 
Few of the meta-analyses, reviews or single studies used as a basis for the benefit assessment 
enabled differentiation of health benefits of breastmilk in a long-term dose-dependent manner. 
Although some of the studies support conclusions that prolonged and exclusive breastfeeding up 
to 6 months of age stimulates protective effects better than shorter duration, the optimal length of 
exclusive and total duration of breastfeeding remains to be settled. 
 
Norwegian Contaminant Exposure Estimates and Tolera ble Intake Levels 
 
Exposure estimates for Norwegian infants were done for PCB-153, DDE, HCB, dioxins and dl-
PCBs. These compounds were the only contaminants where sufficient occurrence data in 
Norwegian breastmilk were available. Furthermore, these compounds were investigated in the 
included studies on possible negative health effects associated with contaminants in breastmilk.  
 
The cumulative amounts pr kg body weight were estimated by combining contaminant 
concentrations in breastmilk from Norwegian women with mean consumption of breastmilk, mean 
fat concentration in breastmilk and the mean body weight in children. 
 
In general, the risks from exposure to contaminants have been assessed by international risk 
assessment bodies such as the Joint FAO/WHO Expert Committee on Food Additives (JECFA) or 
European Food Safety Authority (EFSA). Tolerable intakes have been set for some contaminants 
(e.g. dioxins and dl-PCBs (dioxin-like PCBs)), DDE, HCB and some fluorinated compounds).  
 
For other contaminants, EFSA could not establish tolerable intakes due to lack of data (e.g. PBDEs 
and ndl-PCBs (non dioxin-like PCBs)). However, VKM has previously used a guidance value and 
used this for sum of six ndl-PCBs. 
 
As long as the exposure from breastmilk is below tolerable intakes, exposure in infants is 
considered not to be of concern. It is important to note that tolerable intake values are values 
presumed to be safe. They are not equivalent to levels above which negative health effects are 
likely to occur. Safety margins are incorporated in the values, and exceeding the tolerable intake 
merely results in a reduced safety margin.  
 
The exposure estimates indicate that the DDE and HCB exposure via breastmilk to infants is lower 
than the tolerable daily intakes (TDIs). The guidance value for ndl-PCBs is based on maternal 
                                                           











exposure in cohorts were the infants were breastfed. Exposure estimations in Norwegian women 
indicate that at least 95% of Norwegian infants are exposed to ndl-PCBs below a level which can 
be considered tolerable.  
 
Exceeding the tolerable intake in infants does not necessarily imply that the concentration in the 
infant body reaches a level of concern, and therefore the tolerable intakes of dioxins and dl-PCBs 
are not directly applicable for infants. The tolerable intake of dioxins and dl-PCBs has been set to 
ensure that the contaminant concentration in the mother (the maternal whole body concentration, 
expressed per kg body weight) is below the highest concentration that is considered safe to the 
foetus. This is the body concentration associated with intake similar to the tolerable intake. Due to 
the rapid growth of the infant a dilution of contaminants takes place with a slower increase in body 
concentration.  
 
The dietary intake of dioxins and dl-PCBs, as recently estimated in the Norwegian MoBa cohort, 
was below the tolerable weekly intake (TWI6) for more than 97% of the participating pregnant 
women. This indicates a low risk associated with prenatal exposure among infants in Norway. 
 
Contaminant Exposure in Norwegian Infants in Compar ison with Infants in Included 
Cohorts Addressing Negative Health Effects 
 
The Norwegian levels of PCB-153 and DDE in breastmilk are substantially lower than in most of 
the cohorts included in the risk part of the assessment. However, Norwegian mothers continue 
partial breastfeeding longer than women in most of the studies addressing negative health effects. 
Even when being breastfed for 2 years, the accumulated amount of contaminants in Norwegian 
children will not reach the maximum levels of the included cohorts. Furthermore, the highest body 





The present benefit and risk assessment has included studies that have separated measures of 
pre- and postnatal exposure and associations with the health outcomes. Effects from prenatal 
exposure can be assessed by e.g. investigating association between infant and/or maternal 
exposure levels at birth and health outcomes later in life. However, if postnatal exposure is also of 
importance, it may influence the associations with prenatal exposure. Further, associations 
between postnatal exposure and health outcome may also be influenced by prenatal exposure. 
Although such influence can be adjusted for in statistical analyses, residual influence cannot be 
ruled out. Focusing on studies separating associations with pre-and postnatal exposure was in 
view of VKM the best approach available for this benefit and risk assessment. 
 
Many of the studies on negative effects on neurodevelopment included in the present assessment 
found an association between prenatal contaminant exposure7 and increased risk – an effect not 
observed by postnatal exposure. Hence, assuming equal sensitivity in the pre- and postnatal 
period is probably a conservative approach which most likely overestimates the risk when the 
highest body concentration is reached as late in infancy as 12 months, as in Norway.  
 
Benefit and Risk Assessment by Health Outcome 
 
The literature grading forms the basis of the benefit and risk assessment. Furthermore, the 
evaluation of the benefits and possible risks related to breastmilk is based on Norwegian data on 
prevalence of breastfeeding and concentrations of persistent organic pollutants in breastmilk.  
 
The health outcomes described in the included papers for positive and negative health effects are 
related to the following diseases or conditions: 
                                                           
6The TWI for dioxins and dl-PCBs is 14 pg TEQ/kg body weight/week. 












• Immune response-associated diseases including infections, asthma/wheezing and allergy, 
coeliac disease, inflammatory bowel disease (Crohn’s disease and ulcerative colitis) and 
type 1 diabetes. 
• Growth, overweight and obesity 
• Outcomes related to the metabolic syndrome such as blood-pressure, serum-cholesterol, 
type 2 diabetes and cardiovascular disease 
• Malignant diseases (cancer) 
• Sudden infant death syndrome 
• Thyroid parameters 
• Sexual maturation 
 
The VKM conclusions are organised according to health outcomes, starting with those outcomes 
that have been studied from both a benefit and risk point of view. 
 
Neurodevelopment - IQ and Cognitive Development 
 
Based on systematic reviews and meta-analyses published within the last 10 years, VKM finds that 
the evidence is convincing for an enhancing effect of breastmilk on neurodevelopment. The optimal 
length of exclusive and partial breastfeeding which stimulates the positive effect remains to be 
settled. 
 
The grading of the scientific evidence for negative health effects from persistent organic pollutants 
in breastmilk on neurodevelopment is based on seven cohorts, with findings of increased risk in 
three cohorts (Dutch, German and Canadian cohorts). The findings were transient in the Dutch and 
German cohorts, whereas no follow up study from the Canadian cohort was available. 
 
The evidence is limited suggestive for a negative effect from persistent organic pollutants in 
breastmilk on neurodevelopment at exposure levels in these cohorts. The length of exclusive and 
partial breastfeeding associated with the transient negative effects in some studies remains to be 
settled. As to mercury, this compound was only investigated in one cohort and VKM concludes that 
the evidence for an effect of exposure from breastmilk is limited and no conclusion can be drawn. 
 
A specific confounder challenge for interpretation of studies on neurodevelopment was the lack of 
HOME score measurements. HOME score measurements were used in 7 of the 14 papers 
investigating associations between POP’s in breastmilk and neurodevelopment, including the two 
papers which reported transient findings. 
 
The estimated cumulative amounts per kg body weight of contaminants in infants in the Dutch, 
German and Canadian cohorts were higher than currently in Norway, both prenatally, early 
postnatally and at 1 year of age. Even with a breastfeeding duration of 2 years, the cumulative 
amounts of contaminants in Norwegian infants will not reach similar peak levels as the infants in 
the included cohorts. Furthermore, the highest cumulative amount received by present-day 
Norwegian infants is reached later in infancy than in infants in the included cohorts. Taking the 
methodological challenges and the additional considerations into account, the following conclusion 
is drawn: 
 
VKM Concludes that the Benefits of Breastmilk Clearly Outweigh the Possible Risk of Impaired 
Neurodevelopment from Contaminants in Breastmilk.  
 
Immune Response-associated Diseases  
 
Based on recent systematic reviews and meta-analyses, VKM finds that the grading of the 
evidence on the benefit side is convincing for a protective effect of breastmilk on infections, at least 












The evidence is limited and no conclusion can be drawn for a possible protective effect of 
breastmilk on asthma and wheezing, allergies and atopic dermatitis. 
 
The grading of the scientific evidence for negative health effects from persistent organic pollutants 
in breastmilk on immune response-associated diseases is based on four cohorts, with findings of 
increased risk in three cohorts (Faroe Island 3, Dutch and Slovakian cohorts). The evidence is 
considered limited and no conclusion can be drawn for a negative effect from persistent organic 
pollutants in breastmilk on thymus weight, vaccine antibody titre, respiratory infections, asthma and 
wheezing. VKM notes that although the evidence is limited and inconclusive, this is mainly due to 
the scarcity of studies and disparate endpoint measurements. All studies investigating 
immunological endpoints reported some effect. 
 
In the risk assessment of immune response-associated diseases other than infections, a major 
challenge was the heterogeneity within each main group of outcomes, e.g. immune response- or 
allergy-related diseases, where all five papers included in reality measured widely different 
outcomes, and different parameters of similar outcomes. 
 
The Faroe 3 cohort had approximately 9-fold higher concentrations of PCBs than the present-day 
Norwegian levels. The Slovakian and Dutch cohorts had about 3 to 4 times higher mean breastmilk 
levels than the present levels in Norway. In the INMA (Menorca) cohort DDE was addressed, and 
the mean levels were 100-fold higher than in Norway. 
 
The estimated cumulative amount per kg body weight of contaminants in infants in the Faroese, 
Slovakian and Dutch cohorts were higher than current Norwegian levels, both prenatally, early 
postnatally and at 1 year of age. Even with a breastfeeding duration of 2 years, the cumulative 
amounts of contaminants in Norwegian infants will not reach similar peak levels as the infants in 
the included cohorts. Furthermore, the highest cumulative level in present-day Norwegian infants is 
reached later in infancy than in infants in the included cohorts. 
 
Four of the five studies investigating association between persistent organic pollutants in 
breastmilk and immunological parameters also found an association between prenatal contaminant 
exposure and immune response-associated diseases. The nervous- and immune systems undergo 
substantial development after birth, and have been assumed to be sensitive to chemical exposures 
also in the postnatal period. In the absence of knowledge, a conservative approach would be to 
assume that the infant is as sensitive as the foetus. 
 
Taking the methodological challenges and the additional considerations into account, the following 
conclusion is drawn: 
 
VKM concludes that the benefits of breastmilk in terms of defence against infections clearly 
outweigh the possible risk of reduced resistance to infections from contaminants in breastmilk, 
at least as long as the child is breastfed. 
 
No conclusion can be drawn on other immune response-associated diseases due to 
inconclusive results on the benefit side and few and disperse studies on the risk side. 
 
Growth, Overweight and Obesity 
 
Based on recent systematic reviews and meta-analyses, VKM finds that the evidence is convincing 
for a protective effect of breastmilk on risk of overweight and obesity in childhood. The optimal 
length of exclusive and partial breastfeeding associated with the reduction in risk remains to be 
settled. 
 
Grading the evidence on the risk side, VKM concludes that the evidence is limited and no 
conclusion can be drawn for a possible association between persistent organic pollutants in 
breastmilk and impaired growth in children. The grading of the scientific evidence for negative 











cohorts, with negative findings in one, pointing towards reduced (and not increased) weight with 
increasing PCB exposure (Faroe Island 2). Infants in the Faroese cohorts have historically had 
substantially higher levels of contaminants in blood both at birth as well as early and late in the 
nursing period in comparison with Norwegian infants. 
 
Taking the methodological challenges and the additional considerations into account, the following 
conclusion is drawn: 
 
VKM concludes that the reduced risk of overweight and obesity associated with breastfeeding 




VKM concludes that the evidence for association between postnatal exposure to contaminants and 
parameters related to thyroid hormones is very limited and no conclusion can be drawn. 
 
Type 1 and 2 Diabetes, High Blood Pressure, Crohn’s  Disease, Ulcerative Colitis, Coeliac 
Disease, Childhood Cancer and Sudden Infant Death S yndrome  
 
VKM concludes that the evidence is probable for a protective effect of breastmilk on later risk of 
type 1 diabetes, type 2 diabetes and high blood pressure. The optimal length of exclusive or partial 
breastfeeding which protects remains to be settled. 
 
VKM concludes that the evidence is limited suggestive for a protective effect of breastmilk on the 
risk of Crohn’s disease, ulcerative colitis, coeliac disease, childhood cancer and sudden infant 
death syndrome.  
 
No studies investigating these health outcomes in relation to contaminants in breastmilk were 
identified. 
 
Overall Conclusions on Benefit and Risk Assessment of Breastmilk to Infant Health in 
Norway 
 
Taking the present-day levels of contaminants in breastmilk and the long duration of breastfeeding 
(12 months) in Norway into account, VKM concludes that:  
 
• The benefits of breastmilk clearly outweigh the possible risk of impaired neurodevelopment 
from contaminants in breastmilk.  
• The benefits of breastmilk in terms of defence against infections clearly outweigh the 
possible risk of reduced resistance to infections from contaminants in breastmilk, at least as 
long as the child is breastfed. 
• The reduced risk of overweight and obesity associated with breastfeeding clearly outweighs 
the possible risk presented by contaminants in breastmilk. 
• As regards the beneficial effects of breastmilk on risk of type 1 and type 2 diabetes and high 
blood pressure, the evidence suggests a probable beneficial effect later in life. There are no 
studies investigating these health outcomes in relation to contaminants in breastmilk. 
• No conclusion can be drawn on other immune response-associated diseases due to 
inconclusive results on the benefit side and few and disperse studies on the risk side. 
 
Following a comprehensive assessment of scientific literature on the positive health effects of 
breastmilk and concentrations in breastmilk of compounds representing possible health hazards, 
and given current knowledge about concentrations of contaminants in Norwegian breastmilk and 
breastfeeding duration in Norway, VKM concludes that the benefits associated with breastmilk 
clearly outweigh the risk presented by current levels of contaminants in breastmilk. This conclusion 
is not affected by whether a child is exclusively or partially breastfed up to the age of 6 months and 
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